Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00891735
What this trial is testing

Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)

Who this might be right for
Age-related Macular Degeneration
Genentech, Inc. 1,097
Not applicableUnknownNCT00403026
What this trial is testing

Intravitreal Bevacizumab for Retinal Disorders

Who this might be right for
Wet AMDMacular OedemaProliferative Diabetic Retinopathy
Narayana Nethralaya 150
Very early researchNot Yet RecruitingNCT06888492
What this trial is testing

To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 8
Large-scale testing (Phase 3)Study completedNCT05345236
What this trial is testing

Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Qilu Pharmaceutical Co., Ltd. 366
Testing effectiveness (Phase 2)Study completedNCT01749891
What this trial is testing

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Allegro Ophthalmics, LLC 25
Not applicableWithdrawnNCT04428242
What this trial is testing

Study Evaluating Retinal Health Monitoring System Thickness Module

Who this might be right for
Macular EdemaMacular Degeneration
Kubota Vision Inc.
Post-approval studies (Phase 4)Study completedNCT02581891
What this trial is testing

Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye

Who this might be right for
Macular Degeneration
Bayer 287
Early research (Phase 1)Study completedNCT05903794
What this trial is testing

EXG102-031 in Patients With wAMD (Everest)

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Exegenesis Bio 12
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableStudy completedNCT03290794
What this trial is testing

Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 100
Not applicableStudy completedNCT01473251
What this trial is testing

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Who this might be right for
Exudative Macular DegenerationDiabetic Macular Edema
Vitreo-Retinal Associates, Michigan 16
Early research (Phase 1)Ended earlyNCT04594681
What this trial is testing

A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Healthy VolunteersWet Age-related Macular Degeneration
Kyowa Kirin Co., Ltd. 116
Post-approval studies (Phase 4)Study completedNCT06330220
What this trial is testing

Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity

Who this might be right for
Age-Related Macular Degeneration
Seoul National University Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Study completedNCT03558061
What this trial is testing

Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 30
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Post-approval studies (Phase 4)UnknownNCT01961414
What this trial is testing

Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910

Who this might be right for
Exudative Age-related Macular Degeneration
Palmetto Retina Center, LLC 45
Large-scale testing (Phase 3)Looking for participantsNCT06952452
What this trial is testing

Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Who this might be right for
Wet Age-related Macular Degeneration
Parc de Salut Mar 630
Next Page